In fact, research shows that changing biologics is common. After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

Jojoba oil comes from a medicinal plant with anti-inflammatory properties. This article explains how jojoba could improve ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

Psoriasis can occur near the eyes, causing redness, itching, dryness, and flaking skin. Once it’s correctly diagnosed, you can often manage it with topical treatments.

Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

The National Psoriasis Foundation raised more than $1.5 million during its annual Commit to Cure gala, breaking previous fundraising records and furthering ongoing efforts to find a cure for psoriatic ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...